{"date":"2026-04-23","count":34,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6547-2026-04-23-2238-itw9si","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"22:38:51","subject":"本公司向泰國食品藥物管理局 (Thai FDA) 提交恩穩健腸病毒71型疫苗新藥審查 (NDA)","clause":"第10款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-04-23 22:38，「本公司向泰國食品藥物管理局 (Thai FDA) 提交恩穩健腸病毒71型疫苗新藥審查 (NDA)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-04-23-2021-84656m","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"20:21:04","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"第8款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-04-23 20:21，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-04-23-2019-16uyccm","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"20:19:52","subject":"公告董事會決議召開115年度股東常會相關事宜(增列其他議案)","clause":"第17款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-04-23 20:19，「公告董事會決議召開115年度股東常會相關事宜(增列其他議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-04-23-2016-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"20:16:31","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-04-23 20:16，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-04-23-2004-1vxo8ho","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"20:04:27","subject":"代重要子公司Belite Bio, Inc公告受邀參加Stifel 2026年線上虛擬眼科論壇(Stifel 2026 Virtual Ophthalmology Forum)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-04-23 20:04，「代重要子公司Belite Bio, Inc公告受邀參加Stifel 2026年線上虛擬眼科論壇(Stifel 2026 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-04-23-2004-19l40jr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"20:04:07","subject":"代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright& Co.投資銀行舉辦之第四屆生技交流投資年會(H.C. Wainwright4th Annual BioConnect Investor Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-04-23 20:04，「代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright& Co.投資銀行舉辦之第四屆生技交」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-04-23-2003-o98f4o","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"20:03:46","subject":"代重要子公司Belite Bio, Inc公告受邀參加美國銀行證券(BofA Securities)舉辦之2026醫療論壇(2026 Health Care Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-04-23 20:03，「代重要子公司Belite Bio, Inc公告受邀參加美國銀行證券(BofA Securities)舉辦之2026醫療論」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-04-23-2003-lndy8l","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"20:03:17","subject":"代重要子公司Belite Bio, Inc公告受邀參加DeutscheBank投資銀行舉辦之存託憑證線上投資論壇(DepositaryReceipts Virtual Investor Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-04-23 20:03，「代重要子公司Belite Bio, Inc公告受邀參加DeutscheBank投資銀行舉辦之存託憑證線上投資論壇(Dep」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-04-23-1900-1q5zr1x","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"19:00:07","subject":"公告本公司115年股東常會通過解除法人董事代表人競業禁止之限制案","clause":"第22款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-04-23 19:00，「公告本公司115年股東常會通過解除法人董事代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-04-23-1855-1jb8ii5","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"18:55:59","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-04-23 18:55，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-04-23-1848-185r6rq","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"18:48:35","subject":"公告本公司與Cyto-Facto Inc.簽署委託服務協議，進行CDMO委託開發與製造服務合作。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-04-23 18:48，「公告本公司與Cyto-Facto Inc.簽署委託服務協議，進行CDMO委託開發與製造服務合作。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-23-1839-1wdqg7","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"18:39:14","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告2025年年度股東大會決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-23 18:39，「代重要子公司合富（中國）醫療科技股份有限公司公告2025年年度股東大會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-23-1839-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"18:39:00","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-23 18:39，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-23-1819-1pnl8ae","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-23","time":"18:19:38","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之亞太二期臨床試驗，今日已獲澳洲主管機關HREC核准執行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-23 18:19，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之亞太二期臨床試驗，今日已獲澳洲主管機關HREC核准執行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-04-23-1814-11z16qs","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-04-23","time":"18:14:19","subject":"公司接獲獨立數據監測委員會(IDMC)通知，PL001(CD19嵌合抗原受體T細胞製劑)之療效通過第二期臨床試驗期中分析，達統計上顯著意義","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-04-23 18:14，「公司接獲獨立數據監測委員會(IDMC)通知，PL001(CD19嵌合抗原受體T細胞製劑)之療效通過第二期臨床試驗期中分析」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-04-23-1740-ts0rtz","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"17:40:57","subject":"公告本公司董事會決議召開115年股東常會(增訂報告事項及承認事項)","clause":"第32款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-04-23 17:40，「公告本公司董事會決議召開115年股東常會(增訂報告事項及承認事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-04-23-1730-1916b5f","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"17:30:08","subject":"公告本公司董事會決議115年第一季不分派股利","clause":"第31款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-04-23 17:30，「公告本公司董事會決議115年第一季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-04-23-1729-2iz4hx","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"17:29:55","subject":"公告本公司董事會決議不發放股利","clause":"第31款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-04-23 17:29，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-04-23-1726-8zx5uv","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"17:26:26","subject":"代子公司天津紅日健達康醫藥科技有限公司與枕石生物醫藥科技（珠海）有限公司洽談及簽訂推廣許可協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-04-23 17:26，「代子公司天津紅日健達康醫藥科技有限公司與枕石生物醫藥科技（珠海）有限公司洽談及簽訂推廣許可協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-04-23-1726-5j9yh6","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"17:26:22","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-04-23 17:26，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-04-23-1651-15w1hx6","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"16:51:21","subject":"公告本公司董事會決議召開115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-04-23 16:51，「公告本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-04-23-1650-11skdia","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"16:50:39","subject":"公告本公司執行長、財務長及策略長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-04-23 16:50，「公告本公司執行長、財務長及策略長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-04-23-1648-1oamt6j","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"16:48:25","subject":"公告本公司董事會決議114年度不分派股利","clause":"第31款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-04-23 16:48，「公告本公司董事會決議114年度不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-04-23-1626-wwg3nh","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-04-23","time":"16:26:10","subject":"代重要子公司佳醫健康事業(香港)股份有限公司公告董事會決議發放股利","clause":"第14款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-04-23 16:26，「代重要子公司佳醫健康事業(香港)股份有限公司公告董事會決議發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-04-23-1624-127cvq4","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-04-23","time":"16:24:39","subject":"代重要子公司Excelsior Healthcare Co., Limited公告董事會決議發放股利","clause":"第14款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-04-23 16:24，「代重要子公司Excelsior Healthcare Co., Limited公告董事會決議發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-04-23-1600-qmpqzy","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"16:00:23","subject":"開發中新藥OBP-301進度更新","clause":"第53款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-04-23 16:00，「開發中新藥OBP-301進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-04-23-1550-1478bju","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"15:50:05","subject":"本公司「闌尾炎檢測系統（EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM）」已取得美國食品藥物管理局（FDA）核發之 510(k) 許可。","clause":"第53款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-04-23 15:50，「本公司「闌尾炎檢測系統（EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM）」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-04-23-1520-5rax5d","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"15:20:19","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-04-23 15:20，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-04-23-1519-gpuimt","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"15:19:35","subject":"本公司依公開發行公司資金貸與背書保證處理準則第二十五條第一項第三款及第四款之規定辦理公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-04-23 15:19，「本公司依公開發行公司資金貸與背書保證處理準則第二十五條第一項第三款及第四款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-04-23-1518-2iz4hx","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"15:18:46","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-04-23 15:18，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-04-23-1518-5j9yh6","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-04-23","time":"15:18:00","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-04-23 15:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-04-23-1516-1pedvo6","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"15:16:20","subject":"本公司受邀參加永豐證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-04-23 15:16，「本公司受邀參加永豐證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-23-1455-13eafef","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"14:55:32","subject":"公告本公司調整4/14董事會決議庫藏股轉讓員工股數","clause":"第53款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-23 14:55，「公告本公司調整4/14董事會決議庫藏股轉讓員工股數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-23-1421-maria3","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-23","time":"14:21:09","subject":"公告本公司發行國內第八次及第九次無擔保轉換公司債完成訂價","clause":"第53款","fact_date":"2026-04-23","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-23 14:21，「公告本公司發行國內第八次及第九次無擔保轉換公司債完成訂價」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}